Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Gastrointestinal Endoscopy|December 19, 2006
Residue-free sodium phosphate tablets (OsmoPrep) versus Visicol for colon cleansing: a randomized, investigator-blinded trialLawrence Wruble, Michael Demicco, Jeffrey Medoff, et al.
The Science of the Total Environment|August 9, 2020
Congener patterns of polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls as a useful aid to source identification during a contamination incident in the food chainRon L A P Hoogenboom, Rainer Malisch, Stefan P J van Leeuwen, et al.
The American Journal of Gastroenterology|June 19, 2007
A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansingJohn F Johanson, John W Popp, Lawrence B Cohen, et al.
Environment International|February 11, 2015
The effects of flooding on dioxin and PCB levels in food produced on industrial river catchmentsIain R Lake, Christopher D Foxall, Alwyn Fernandes, et al.
The Science of the Total Environment|November 28, 2020
Concentrations of organic contaminants in industrial and municipal bioresources recycled in agriculture in the UKHannah Rigby, Alan Dowding, Alwyn Fernandes, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 2, 2019
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive ShockFortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive ShockFortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, et al.
The American Journal of Gastroenterology|October 13, 2006
Safety and colon-cleansing efficacy of a new residue-free formulation of sodium phosphate tabletsDouglas K Rex, Howard Schwartz, Michael Goldstein, et al.
Toxicology|April 18, 2012
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific contextRichard J Wall, Guochun He, Michael S Denison, et al.
American Heart Journal|May 15, 2018
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?Noel Chan, Philip T Sager, Jack Lawrence, et al.
Pageof 10